The International Society for the Study of Xenobiotics (ISSX) is a community of accomplished researchers and future scientists from academia and industry collaborating to advance the collective knowledge of xenobiotics. The program will cover toxicology, pharmacology, molecular biology, and other related disciplines.
Meet with our scientists at the ISSX/MDO joint meeting.
Poster Presentation
Validation of an MFLC-MS/MS Assay for the Quantitative Analysis of a Novel Peptide, AT-01, Extracted from K2EDTA Plasma
Tara O’Brien (Presenter), Chad Christianson, Daniel Kim, Sangeetha Bollini, Andrew Vick
Tuesday, September 13, 2022
Session 1: 1:30-2:30 PM – P2
Abstract
Exhibitor
Booth #29
September 11-14, 2022
Seattle, WA
The Boston Society focuses on bringing the best scientific ideas to industrial practice. The annual forum on Applied Pharmaceutical Analysis is a full-spectrum program of activities encompassing mechanistic understanding, facets of development processes, and the technologies necessary to discover and develop novel therapeutic entities.
Engage with our scientific team for insightful discussions.
Panel Discussion
ICH:M10
Brian Booth, Malaz Abutarif, Jennifer Zimmer, Jenifer Vija, and Salahedin Hamed
Monday, September 19, 2022
Session 1: 10:05-10:30 AM
Silver Sponsor
Booth #3
September 19-21, 2022
Waltham, MA
The Workshop on Recent Issues in Bioanalysis (WRIB) showcases industry leaders and regulators, providing insights into emerging approaches to innovative science and the latest advice on evolving regulations. The organization promotes the exchange of knowledge and sharing of ideas through presentations of novel case studies with open discussion groups in a social setting.
Exhibitor
Booth #36
September 26-30, 2022
Atlanta, GA
Future Events
AAPS PharmSci 360
16-19 Oct
Boston, MA
ACT 2022
13-16 Nov
Denver, CO
Select Presentations
Visit the Alturas Analytics website for a full listing of presentations and publications.
Accurate and Precise Quantitation of the Phosphorothioate Oligonucleotide Mipomersen from Human Plasma by MFLC-MS/MS
Chad Christianson, TIDES USA: Oligonucleotide and Peptide Therapeutics
Abstract | Poster | Tech Note
Communication Skills Promote Compliant Outcomes
Rachel Walker, RQAP-GLP, 38th Society of Quality Assurance Annual Meeting & Quality College
Abstract | Poster
Developing a Rugged Chiral Assay for the Biomarker 2-Hydroxyglutaric Acid for Use in Routine Clinical Analysis of Plasma Samples from Oncology Studies
Presented by Jennifer Zimmer, PhD, Applied Pharmaceutical Analysis
Abstract | Slides | Video Presentation
